These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20587543)

  • 1. The ELF panel: a new crystal ball in hepatology?
    Pinzani M
    Gut; 2010 Sep; 59(9):1165-7. PubMed ID: 20587543
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of liver fibrosis in clinical practice].
    Abenavoli L; Leggio L; Gasbarrini G; Addolorato G
    Recenti Prog Med; 2006 Sep; 97(9):481-5. PubMed ID: 17017301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding serum sodium to model for end-stage liver disease: identifying those most at risk.
    Crawford DH; Stuart K
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1804-6. PubMed ID: 20002937
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical application of non-invasive diagnosis for hepatic fibrosis].
    Cho SW; Cheong JY
    Korean J Hepatol; 2007 Jun; 13(2):129-37. PubMed ID: 17585186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive evaluation of hepatic fibrosis: don't count your chickens before they're hatched.
    Pinzani M
    Gut; 2006 Mar; 55(3):310-2. PubMed ID: 16474104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of blood panel markers in the diagnosis of hepatic fibrosis].
    Zeng MD; Mao YM; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):163-5. PubMed ID: 18364067
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    Pagadala M; Zein CO; McCullough AJ
    Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive biochemical markers of liver fibrosis.
    Grigorescu M
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):149-59. PubMed ID: 16802010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive measurement of liver fibrosis: application of the FibroScan in hepatology.
    Verveer C; de Knegt RJ
    Scand J Gastroenterol Suppl; 2006; (243):85-8. PubMed ID: 16782627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAHA model: an alternative non-invasive predictor of liver cirrhosis in patients with chronic hepatitis B infection.
    Ayonrinde OT; Olynyk JK
    J Gastroenterol Hepatol; 2010 Jan; 25(1):3-4. PubMed ID: 20136968
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serologic diagnosis of liver fibrosis].
    Sauerbruch T
    Dtsch Med Wochenschr; 1999 Oct; 124(41):1191. PubMed ID: 10572514
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.
    Denzer UW; Lüth S
    Best Pract Res Clin Gastroenterol; 2009; 23(3):453-60. PubMed ID: 19505671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic approaches in the search for biomarkers of liver fibrosis.
    Cowan ML; Rahman TM; Krishna S
    Trends Mol Med; 2010 Apr; 16(4):171-83. PubMed ID: 20304704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
    Bedossa P
    Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive measures of liver fibrosis.
    Rockey DC; Bissell DM
    Hepatology; 2006 Feb; 43(2 Suppl 1):S113-20. PubMed ID: 16447288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum hyaluronan as a possible biomarker of liver insufficiency in cirrhotic patients.
    Grzeszczuk A; Chlabicz S; Panasiuk A
    Rocz Akad Med Bialymst; 2002; 47():80-5. PubMed ID: 12533949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the applicability of noninvasive fibrosis markers in HIV/HCV co-infected patients.
    Schiavon LL; Filho RJ; Narciso JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
    Hepatology; 2007 Jan; 45(1):257-8. PubMed ID: 17187416
    [No Abstract]   [Full Text] [Related]  

  • 18. [Atrial natriuretic paptide in liver cirrhosis].
    Krstić M; Abramović D; Tomić D; Jesić R; Janković G; Marisavljević D; Ivanović B
    Srp Arh Celok Lek; 1994; 122(3-4):86-8. PubMed ID: 17972817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum markers of liver fibrosis].
    Schuppan D; Jax C; Hahn EG
    Dtsch Med Wochenschr; 1999 Oct; 124(41):1213-8. PubMed ID: 10572522
    [No Abstract]   [Full Text] [Related]  

  • 20. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
    Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
    J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.